Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020
NEW YORK, March 24, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its inaugural event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.
Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:15 AM ET on Thursday, March 26th with the first live webcast at 9:30 AM ET.
REGISTER NOW AT: https://tinyurl.com/LSIF032620-AgendaPR
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend the live presentations or ask questions.
Agenda and presenting companies:
| Eastern Time (ET) | Company | Ticker |
| 9:30 AM | RedHill Biopharma Ltd. | Nasdaq: RDHL |
| 10:00 AM | Nuvo Pharmaceuticals Inc. | OTCQX: NRIFF | TSX: NRI |
| 10:30 AM | Orexo AB | OTCQX: ORXOY | Nasdaq STO: ORX |
| 11:00 AM | Emmaus Life Sciences, Inc. | OTCQB: EMMA |
| 11:30 AM | Moleculin Biotech, Inc. | Nasdaq: MBRX |
| 12:00 PM | Lexaria Bioscience Corp. | OTCQX: LXRP | CSE: LXX |
| 12:30 PM | Beroni Group Ltd. | OTCQX: BNIGF | NSX: BTG |
To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com.
About Life Sciences Investor Forum Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.
A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
CONTACT Life Sciences Investor Forum John M. Viglotti SVP Corporate Services, Investor Access (212) 220-2221 johnv@lifesciencesinvestorforum.com
